Sirolimus‐induced interstitial lung disease following pediatric stem cell transplantation

E-ISSN： 1399-3046|19|3|E75-E77

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.19, Iss.3, 2015-05, pp. : E75-E77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic Veno-Occlusive Disease following Hematopoietic Stem Cell Transplantation

Acta Haematologica, Vol. 106, Iss. 1-2, 2001-09 ,pp. : 57-68

Karger

Access to resources Recommend Favorite

Erlotinib Achieved Partial Response in a Non-Small Cell Lung Cancer Patient with Gefitinib-Induced Interstitial Lung Disease

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 464-466

Karger

Access to resources Recommend Favorite

Interstitial Lung Disease Induced by Drugs and Radiation

Respiration, Vol. 71, Iss. 4, 2004-08 ,pp. : 301-326

Karger

Access to resources Recommend Favorite

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 683-688

Karger

Access to resources Recommend Favorite

Mycophenolate mofetil for treatment of steroid‐refractory acute graft‐versus‐host disease after pediatric hematopoietic stem cell transplantation

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 652-658

John Wiley & Sons Inc

Access to resources Recommend Favorite